A
002821
vs
LLY
A
002821
LLY
Over the past 12 months, Asymchem Laboratories Tianjin Co Ltd has outperformed LLY, delivering a return of +27% compared to the LLY's +7% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
002821
LLY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
A
Intrinsic Value
46.09
CNY
Overvaluation 54%
LLY
Intrinsic Value
613.13
USD
Overvaluation 31%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
|
99.9
CNY
|
|||||
|
Eli Lilly and Co
NYSE:LLY
|
886.63
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
002821, LLY
002821, LLY
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
A
|
Asymchem Laboratories Tianjin Co Ltd
Revenue
|
|||||||||||
|
|
Eli Lilly and Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
002821, LLY
002821, LLY
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
A
|
Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
|
|||||||||
|
|
Eli Lilly and Co
NYSE:LLY
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Asymchem Laboratories Tianjin Co Ltd
40.4%
LLY
83%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Operating Margin
Asymchem Laboratories Tianjin Co Ltd
13.3%
LLY
45.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Net Margin
Asymchem Laboratories Tianjin Co Ltd
16.5%
LLY
31.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
FCF Margin
Asymchem Laboratories Tianjin Co Ltd
4.3%
LLY
9.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROE
Asymchem Laboratories Tianjin Co Ltd
6.1%
LLY
101.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROA
Asymchem Laboratories Tianjin Co Ltd
5.4%
LLY
21.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROIC
Asymchem Laboratories Tianjin Co Ltd
6.2%
LLY
27.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROCE
Asymchem Laboratories Tianjin Co Ltd
4.8%
LLY
46.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Solvency Comparison
A
Asymchem Laboratories Tianjin Co...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
002821, LLY
002821, LLY
Performance By Year
002821, LLY
002821, LLY
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 002821 to other stocks
JNJ
Johnson & Johnson
Cheaper
vs Asymchem Laboratories Tianjin...
ROG
Roche Holding AG
Cheaper
vs Asymchem Laboratories Tianjin...
AZN
AstraZeneca PLC
Cheaper
vs Asymchem Laboratories Tianjin...
MRK
Merck & Co Inc
Cheaper
vs Asymchem Laboratories Tianjin...
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
